Inventor · disambiguated record
David J. Harris
Also filed as: HARRIS DAVID · HARRIS DAVID J
32 granted patents·15 pending applications·1,658 citations·filing 1994–2019
98Inventor score
Top patents by PatentIndex Score
47 records- 0196US7615573B2Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitorsUNIV MICHIGAN·Filed 2007·Granted Nov 10, 2009·36 cites·30 claims
- 0296US7196205B2Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitorsGENZYME CORP·Filed 2005·Granted Mar 27, 2007·51 cites·16 claims
- 0396US5948767ACationic amphiphile/DNA complexesGENZYME CORP·Filed 1996·Granted Sep 7, 1999·271 cites·13 claims
- 0495US7253185B2Amino ceramide-like compounds and therapeutic methods of useGENZYME CORP·Filed 2005·Granted Aug 7, 2007·49 cites·4 claims
- 0595US6916802B2Amino ceramide-like compounds and therapeutic methods of useUNIV MICHIGAN·Filed 2004·Granted Jul 12, 2005·64 cites·14 claims
- 0695US5767099ACationic amphiphiles containing amino acid or dervatized amino acid groups for intracellular delivery of therapeutic moleculesGENZYME CORP·Filed 1995·Granted Jun 16, 1998·201 cites·22 claims
- 0794US5783565ACationic amphiphiles containing spermine or spermidine cationic group for intracellular delivery of therapeutic moleculesGENZYME CORP·Filed 1996·Granted Jul 21, 1998·123 cites·4 claims
- 0894US5719131ACationic amphiphiles containing dialkylamine lipophilic groups for intracellular delivery of therapeutic moleculesGENZYME CORP·Filed 1995·Granted Feb 17, 1998·119 cites·24 claims
- 0992US6071890AOrgan-specific targeting of cationic amphiphile/DNA complexes for gene therapyGENZYME CORP·Filed 1995·Granted Jun 6, 2000·128 cites·14 claims
- 1090US8304447B22-acylaminopropoanol-type glucosylceramide synthase inhibitorsSIEGEL CRAIG·Filed 2008·Granted Nov 6, 2012·18 cites·20 claims
- 1189US5935936ACompositions comprising cationic amphiphiles and co-lipids for intracellular delivery of therapeutic moleculesGENZYME CORP·Filed 1996·Granted Aug 10, 1999·85 cites·20 claims
- 1289US5650096ACationic amphiphiles for intracellular delivery of therapeutic moleculesGENZYME CORP·Filed 1994·Granted Jul 22, 1997·92 cites·7 claims
- 1388US8309593B22-acylaminopropoanol-type glucosylceramide synthase inhibitorsSIEGEL CRAIG·Filed 2009·Granted Nov 13, 2012·15 cites·15 claims
- 1488US5925628ACationic amphiphiles for intracellular delivery of therapeutic moleculesGENZYME CORP·Filed 1997·Granted Jul 20, 1999·66 cites·22 claims
- 1587US8940776B22-acylaminopropoanol-type glucosylceramide synthase inhibitorsSIEGEL CRAIG·Filed 2012·Granted Jan 27, 2015·11 cites·19 claims
- 1682US9272996B22-acylaminopropoanol-type glucosylceramide synthase inhibitorsSIEGEL CRAIG·Filed 2012·Granted Mar 1, 2016·6 cites·16 claims
- 1782US5948925ACationic amphiphiles containing linkers derived from neutral or positively charged amino acidsGENZYME CORP·Filed 1997·Granted Sep 7, 1999·49 cites·14 claims
- 1881US5939401ACationic amphiphile compositions for intracellular delivery of therapeutic moleculesGENZYME CORP·Filed 1996·Granted Aug 17, 1999·37 cites·5 claims
- 1980US5840710ACationic amphiphiles containing ester or ether-linked lipophilic groups for intracellular delivery of therapeutic moleculesGENZYME CORP·Filed 1995·Granted Nov 24, 1998·51 cites·36 claims
- 2079US9745294B22-acylaminopropoanol-type glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2014·Granted Aug 29, 2017·3 cites·24 claims
- 2179US8900560B2Amide dendrimer compositionsSANOFI SA·Filed 2013·Granted Dec 2, 2014·3 cites·2 claims
- 2275US5910487ACationic amphiphiles and plasmids for intracellular delivery of therapeutic moleculesGENZYME CORP·Filed 1995·Granted Jun 8, 1999·28 cites·7 claims
- 2374US6383814B1Cationic amphiphiles for intracellular delivery of therapeutic moleculesGENZYME CORP·Filed 1999·Granted May 7, 2002·32 cites·16 claims
- 2474US5942634ACationic amphiphiles for cell transfectionsGENZYME CORP·Filed 1997·Granted Aug 24, 1999·27 cites·11 claims
- 2572US9744153B22-acylaminopropoanol-type glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2016·Granted Aug 29, 2017·1 cites·14 claims
- 2669US5747471ACationic amphiphiles containing steroid lipophilic groups for intracellular delivery of therapeutic moleculesGENZYME CORP·Filed 1995·Granted May 5, 1998·37 cites·20 claims
- 2765US2009155368A1Pharmaceutical compositionsGENZYME CORP·Filed 2008·Application pending·0 cites
- 2863US9066972B2Amide dendrimer compositionsGENZYME CORP·Filed 2014·Granted Jun 30, 2015·0 cites·3 claims
- 2962US2011142952A1Pharmaceutical CompositionsHARRIS DAVID J·Filed 2009·Application pending·0 cites
- 3061US8425887B2Amide dendrimer compositionsDHAL PRADEEP K·Filed 2007·Granted Apr 23, 2013·0 cites·2 claims
- 3161US2019240252A1Pharmaceutical compositionsGENZYME CORP·Filed 2019·Application pending·0 cites
- 3260US5912239AImidazole-containing cationic amphiphiles for intracellular delivery of therapeutic moleculesGENZYME CORP·Filed 1997·Granted Jun 15, 1999·22 cites·6 claims
- 3360US2014322319A1Pharmaceutical compositionsGENZYME CORP·Filed 2014·Application pending·0 cites
- 3460US2009312392A1Amino ceramide-like compounds and therapeutic methods of useSHAYMAN JAMES A·Filed 2009·Application pending·0 cites
- 3557US2017152347A1Amide dendrimer compositionsGENZYME CORP·Filed 2016·Application pending·0 cites
- 3657US2018093981A12-Acylaminopropoanol-Type Glucosylceramide Synthase InhibitorsGENZYME CORP·Filed 2017·Application pending·0 cites
- 3756US5952516ACationic amphiphiles containing multiplesteroid lipophilic groupsGENZYME CORP·Filed 1997·Granted Sep 14, 1999·12 cites·10 claims
- 3855US6331524B1Organ-specific targeting of cationic amphiphile / DNA complexes for gene therapyGENZYME CORP·Filed 1997·Granted Dec 18, 2001·11 cites·4 claims
- 3955US2010234309A1Dendrimer CompositionsGENZYME CORP·Filed 2007·Application pending·0 cites
- 4055US2008146533A1Amino ceramide-like compounds and therapeutic methods of useSHAYMAN JAMES A·Filed 2007·Application pending·0 cites
- 4154US2015094379A1Dendrimer CompositionsGENZYME CORP·Filed 2014·Application pending·0 cites
- 4252US2015321996A1Amide dendrimer compositionsGENZYME CORP·Filed 2015·Application pending·0 cites
- 4352US2016158275A1Pharmaceutical compositionsGENZYME CORP·Filed 2015·Application pending·0 cites
- 4448US6323191B1Small molecule chloride transportGENZYME CORP·Filed 1999·Granted Nov 27, 2001·10 cites·15 claims
- 4532US2018228826A1Fixed-dose combinations of antiviral compoundsMERCK SHARP & DOHME·Filed 2016·Application pending·0 cites
- 4631US2018228827A1Fixed-dose combinations of antiviral compoundsMERCK SHARP & DOHME·Filed 2016·Application pending·0 cites
- 4730US2002013282A1Cationic amphipile compositions for interacelluar delivery of therapeutic moleculesFiled 1998·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David J. Harris files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →